Skip to content

    Vensana

        * Our Team
        * Values
        * Our Entrepreneurs

        Our Entrepreneurs

        We are proud to have been the capital partner to some of the most talented medtech teams in our industry. Our entrepreneurs have pioneered new treatments for chronic diseases, built entirely new commercial markets from the ground up, and ushered in the future of personalized medicine and connected care.

            All Vensana Active Legacy
            All
              All Vensana Active Legacy

              Acquired by Stryker

              Acquired by Boston Scientific

              Acquired by Edwards Lifesciences

              Acquired by Wright Medical

              Acquired by Alcon

              Acquired by Covidien

              IPO (NASDAQ: CVRX)

              Acquired by Medtronic

              IPO (NASDAQ: NARI)

              Acquired by Philips

              Acquired by CR Bard

              Acquired by Johnson & Johnson

              Acquired by Labcorp

              Acquired by Boston Scientific

              IPO (NYSE American: SENS)

              Acquired by Terumo

              Acquired by Abbott

              Acquired by Merz

              Acquired by Olympus

              Acquired by Boston Scientific

              Acquired by Philips

          21

            Novel FDA PMA & de novo 510k approvals

          60

            U.S. Commercial Product Launches

          40

            Level I Clinical Trials

          32

            Strategic Financings

          31

            Exits by IPO or M&A

      VENSANA CAPITAL

      CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

      Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

      Get in Touch

          Our Latest

          See All News
            Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology
            Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies
            Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program
            Resources
          News LP Access
            Contact
          [email protected] 612.217.8680
            Engage
            Minneapolis
          Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
            Washington, D.C.
          Vensana Capital 101 Church Street Suite D Vienna, VA 22180

          © 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions